Cargando…
Lobohedleolide suppresses hepatitis C virus replication via JNK/c-Jun-C/EBP-mediated down-regulation of cyclooxygenase-2 expression
Hepatitis C virus (HCV) chronically infects 2–3% people of the global population, which leads to liver cirrhosis and hepatocellular carcinoma. Drug resistance remains a serious problem that limits the effectiveness of US Food and Drug Administration (FDA)-approved direct-acting antiviral (DAA) drugs...
Autores principales: | Lin, Chun-Kuang, Tseng, Chin-Kai, Liaw, Chih-Chuang, Huang, Chiung-Yao, Wei, Chih-Ku, Sheu, Jyh-Horng, Lee, Jin-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989199/ https://www.ncbi.nlm.nih.gov/pubmed/29875371 http://dx.doi.org/10.1038/s41598-018-26999-w |
Ejemplares similares
-
Combinatorial Recruitment of CREB, C/EBPβ and c-Jun Determines Activation of Promoters upon Keratinocyte Differentiation
por: Rozenberg, Julian M., et al.
Publicado: (2013) -
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation
por: Anfinogenova, Nina D., et al.
Publicado: (2020) -
The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
por: Chen, Jing, et al.
Publicado: (2021) -
Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer
por: Cai, Jun, et al.
Publicado: (2017) -
Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma
por: Wei, Kai, et al.
Publicado: (2019)